Nektar Therapeutics (NKTR)
1.255
-0.06
(-4.92%)
USD |
NASDAQ |
Apr 19, 16:00
1.27
+0.02
(+1.20%)
After-Hours: 20:00
Nektar Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 254.14M |
December 31, 2019 | 252.89M |
September 30, 2019 | 248.26M |
June 30, 2019 | 247.82M |
March 31, 2019 | 247.39M |
December 31, 2018 | 246.95M |
September 30, 2018 | 246.51M |
June 30, 2018 | 246.08M |
March 31, 2018 | 245.64M |
December 31, 2017 | 245.21M |
Date | Value |
---|---|
September 30, 2017 | 244.77M |
June 30, 2017 | 244.34M |
March 31, 2017 | 243.90M |
December 31, 2016 | 243.46M |
September 30, 2016 | 243.00M |
June 30, 2016 | 242.57M |
March 31, 2016 | 242.13M |
December 31, 2015 | 241.70M |
September 30, 2015 | 125.00M |
June 30, 2015 | 125.00M |
March 31, 2015 | 125.00M |
December 31, 2014 | 125.00M |
September 30, 2014 | 125.00M |
June 30, 2014 | 125.00M |
March 31, 2014 | 125.00M |
December 31, 2013 | 125.00M |
September 30, 2013 | 125.00M |
June 30, 2013 | 125.00M |
March 31, 2013 | 125.00M |
December 31, 2012 | 125.00M |
September 30, 2012 | 125.00M |
June 30, 2012 | 214.96M |
March 31, 2012 | 214.96M |
December 31, 2011 | 214.96M |
September 30, 2011 | 214.96M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
254.14M
Maximum
Mar 2020
52.80M
Average
--
Median
Jun 2020
Total Long Term Debt (Quarterly) Benchmarks
Stereotaxis Inc | 0.00 |
Vanda Pharmaceuticals Inc | 0.00 |
Cara Therapeutics Inc | 0.00 |
Marinus Pharmaceuticals Inc | 72.97M |
DiaMedica Therapeutics Inc | -- |